267 related articles for article (PubMed ID: 28301280)
1. Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.
Honda-Okubo Y; Rajapaksha H; Sajkov D; Gordon D; Cox MMJ; Petrovsky N
Hum Vaccin Immunother; 2017 Jun; 13(6):1-11. PubMed ID: 28301280
[TBL] [Abstract][Full Text] [Related]
2. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.
Honda-Okubo Y; Ong CH; Petrovsky N
Vaccine; 2015 Sep; 33(38):4892-900. PubMed ID: 26232344
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.
Gordon DL; Sajkov D; Woodman RJ; Honda-Okubo Y; Cox MM; Heinzel S; Petrovsky N
Vaccine; 2012 Aug; 30(36):5407-16. PubMed ID: 22717330
[TBL] [Abstract][Full Text] [Related]
4. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.
Gordon DL; Sajkov D; Honda-Okubo Y; Wilks SH; Aban M; Barr IG; Petrovsky N
Vaccine; 2016 Jul; 34(33):3780-6. PubMed ID: 27342914
[TBL] [Abstract][Full Text] [Related]
5. An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.
Honda-Okubo Y; Bart Tarbet E; Hurst BL; Petrovsky N
Vaccine; 2023 Sep; 41(39):5730-5741. PubMed ID: 37567799
[TBL] [Abstract][Full Text] [Related]
6. Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge.
Tomar J; Patil HP; Bracho G; Tonnis WF; Frijlink HW; Petrovsky N; Vanbever R; Huckriede A; Hinrichs WLJ
J Control Release; 2018 Oct; 288():199-211. PubMed ID: 30218687
[TBL] [Abstract][Full Text] [Related]
7. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
Treanor JJ; Chu L; Essink B; Muse D; El Sahly HM; Izikson R; Goldenthal KL; Patriarca P; Dunkle LM
Vaccine; 2017 Feb; 35(6):923-928. PubMed ID: 28089141
[TBL] [Abstract][Full Text] [Related]
8. HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice.
Kang X; Yang Y; Jiao Y; Song H; Song L; Xiong D; Wu L; Pan Z; Jiao X
J Mol Microbiol Biotechnol; 2016; 26(6):422-432. PubMed ID: 27721310
[TBL] [Abstract][Full Text] [Related]
9. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
[TBL] [Abstract][Full Text] [Related]
10. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.
Wong TM; Petrovsky N; Bissel SJ; Wiley CA; Ross TM
Hum Vaccin Immunother; 2016 Aug; 12(8):2096-2105. PubMed ID: 27215855
[TBL] [Abstract][Full Text] [Related]
11. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
Mittal N; Sengupta N; Malladi SK; Reddy P; Bhat M; Rajmani RS; Sedeyn K; Saelens X; Dutta S; Varadarajan R
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578291
[TBL] [Abstract][Full Text] [Related]
12. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
Allen JD; Ross TM
J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
[TBL] [Abstract][Full Text] [Related]
13. Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.
Ikematsu H; Nagai H; Kawashima M; Kawakami Y; Tenjinbaru K; Li P; Walravens K; Gillard P; Roman F
Hum Vaccin Immunother; 2012 Feb; 8(2):260-6. PubMed ID: 22426369
[TBL] [Abstract][Full Text] [Related]
14. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
Shoji Y; Chichester JA; Jones M; Manceva SD; Damon E; Mett V; Musiychuk K; Bi H; Farrance C; Shamloul M; Kushnir N; Sharma S; Yusibov V
Hum Vaccin; 2011; 7 Suppl():41-50. PubMed ID: 21266846
[TBL] [Abstract][Full Text] [Related]
15. The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.
Jul-Larsen Å; Madhun AS; Brokstad KA; Montomoli E; Yusibov V; Cox RJ
Hum Vaccin Immunother; 2012 May; 8(5):653-61. PubMed ID: 22634440
[TBL] [Abstract][Full Text] [Related]
16. Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.
Shim BS; Choi JA; Song HH; Park SM; Cheon IS; Jang JE; Woo SJ; Cho CH; Song MS; Kim H; Song KJ; Lee JM; Kim SW; Song DS; Choi YK; Kim JO; Nguyen HH; Kim DW; Bahk YY; Yun CH; Song MK
J Microbiol; 2013 Feb; 51(1):130-5. PubMed ID: 23456722
[TBL] [Abstract][Full Text] [Related]
17. Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate.
Gong M; Zhou J; Yang C; Deng Y; Zhao G; Zhang Y; Wang Y; Zhou Y; Tan W; Xu H
Vaccine; 2012 Dec; 30(52):7498-505. PubMed ID: 23116697
[TBL] [Abstract][Full Text] [Related]
18. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection.
Honda-Okubo Y; Kolpe A; Li L; Petrovsky N
Vaccine; 2014 Aug; 32(36):4651-9. PubMed ID: 24958701
[TBL] [Abstract][Full Text] [Related]
20. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
